Indoco Remedies Ltd Quarterly Results
Q2 FY26-27 Results Summary
Revenue
The revenue stands at ₹520.17 crore, reflecting a quarter-on-quarter *(QoQ) increase of 11.27 per cent from ₹467.50 crore. This corresponds to a year-on-year *(YoY) growth of 7.32 per cent.
Operating Profit
Operating Profit stands at ₹46.43 crore, reflecting a quarter-on-quarter *(QoQ) increase of 13.19 per cent from ₹41.02 crore. This corresponds to a year-on-year *(YoY) growth of 9.20 per cent.
PBDT
PBDT stands at ₹58.63 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 47.77 per cent from ₹112.25 crore. This corresponds to a year-on-year *(YoY) growth of 213.19 per cent.
Profit Before Tax
Profit Before Tax stands at ₹24.19 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 68.88 per cent from ₹77.72 crore. This corresponds to a year-on-year *(YoY) growth of 278.79 per cent.
Net Profit
Net Profit stands at ₹19.47 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 70.25 per cent from ₹65.44 crore. This represents a 311.40 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Indoco Remedies Ltd Earnings
- YOY
- QOQ
Indoco Remedies Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Indoco Remedies Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Indoco Remedies Ltd Financial Reports
Indoco Remedies Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Indoco Remedies | -0.12% | 2.95% | -13.44% | -3.31% | -5.90% | -17.67% |
| Dishman Carbogen | 2.32% | 6.44% | 0.75% | -20.59% | -18.32% | -38.06% |
| Panacea Biotec | 3.90% | 11.07% | -4.45% | -16.76% | -12.83% | -16.12% |
| Sai Parenteral's | 1.91% | -8.06% | -8.89% | -11.53% | -5.72% | 17.86% |
| Hester Bios | 2.41% | 0.86% | 6.03% | -5.35% | 40.05% | 45.15% |
| Syncom Formul. | 8.17% | 7.27% | -11.14% | 56.56% | 43.70% | 28.50% |
| Venus Remedies | 5.66% | 12.44% | -22.14% | -11.36% | 49.81% | 208.56% |
Company Info
Company Information
Chairman & Non Executive Dir. : Suresh G Kare
ED / MD / Promoter : Aditi Kare Panandikar
Joint MD & Executive Director : Sundeep V Bambolkar
Independent Non Exe. Director : Satish Shenoy
Independent Non Exe. Director : Ajay Mulgaokar
Independent Non Exe. Director : Vasudha V Kamat
Independent Non Exe. Director : Abhijit Y Gore
CS / Compliance Officer / Legal Head : RAMANATHAN HARIHARAN